Paydirt
KG
Insider

Kathleen Goin

Chief Operating Officer

Kathleen Goin (Chief Operating Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Palvella Therapeutics, Inc. (PVLA). The largest single filing was $655K of PVLA (4,302 sh across 3 lots, as filed), executed Sep 16.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.9M
shares × price, as filed
Last traded
Sep 16
Filed Sep 18

Median ADV $37.6M across their filed names

Open performance
Volume by month
$655K$327K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2025 · sells $371KDec 2025 · sells $415KJan 2026 · sells $367KFeb 2026 · sells $342KMar 2026 · sells $471KApr 2026 · sells $380KMay 2026 · sells $371KJun 2026 · sells $474KJul 2026 · sells $565KAug 2026 · sells $530KSep 2026 · sells $655K
Buys $0 Sells $4.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names
PVLA Palvella Therapeutics, Inc. PVLA · 0 buys · 11 sells 11 filings
Recent filings
PVLASALE Palvella Therapeutics, Inc. View filing → $367K
3,749 sh × $97.94
Exec Jan 21
Filed Jan 23 · 5:30 PM ET
PVLASALE Palvella Therapeutics, Inc. View filing → $415K
4,302 sh × $96.47
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET
PVLASALE Palvella Therapeutics, Inc. View filing → $371K
4,302 sh across 2 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET